Literature DB >> 15389356

Helicobacter pylori and idiopathic central serous chorioretinopathy.

Cristiano Giusti1, Martine Mauget-Faÿsse.   

Abstract

Idiopathic central serous chorioretinopathy (ICSC) is a disease that typically affects middleaged adults and involves the sensory retina, the retinal pigment epithelium (RPE) and the choroid. Patients usually have mild visual loss. ICSC generally resolves without therapy, although the disease can become chronic with ensuing RPE decompensation. Some patients, particularly older adults, can also develop choroidal subretinal neovascularisations (CNV), which may lead to a severe loss in visual acuity. Although the aetiopathogenesis of the disease is still incompletely understood, a correlation with psychophysical stress supports the idea that the disease may be "adrenergically conditioned", leading to the development of one or several defects in the RPE, with subsequent focal leakage of serous fluid and its retention in the subretinal space. An association between ICSC and the Helicobacter pylori (HP) infection has also been recently documented, suggesting that this organism may possibly be involved in the development of some cases of ICSC. Pathogenetic mechanisms that may explain the contribution of HP in the development of ICSC are postulated.

Entities:  

Mesh:

Year:  2004        PMID: 15389356     DOI: 2004/27/smw-10517

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  5 in total

1.  Clinical efficiency of Helicobacter pylori eradication in the treatment of patients with acute central serous chorioretinopathy.

Authors:  Olesya Zavoloka; Pavlo Bezditko; Irina Lahorzhevska; Darya Zubkova; Yevgeniya Ilyina
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-03-16       Impact factor: 3.117

Review 2.  Oral medications for central serous chorioretinopathy: a literature review.

Authors:  William Fusi-Rubiano; Habiba Saedon; Vijay Patel; Yit C Yang
Journal:  Eye (Lond)       Date:  2019-09-16       Impact factor: 3.775

3.  Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy.

Authors:  Antonio Marcelo Barbante Casella; Rodrigo Fabri Berbel; Gláucio Luciano Bressanim; Marcus Rudolph Malaguido; José Augusto Cardillo
Journal:  Clinics (Sao Paulo)       Date:  2012-09       Impact factor: 2.365

4.  The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy.

Authors:  Mohammad Bagher Rahbani-Nobar; Alireza Javadzadeh; Leila Ghojazadeh; Mandana Rafeey; Amir Ghorbanihaghjo
Journal:  Mol Vis       Date:  2011-01-11       Impact factor: 2.367

Review 5.  Advances in the treatment of central serous chorioretinopathy.

Authors:  Marwan A Abouammoh
Journal:  Saudi J Ophthalmol       Date:  2015-01-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.